2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Melanoma
26
Neuroblastoma
25
Breast Neoplasms
20
Prostatic Neoplasms
18
Leukemia
15
Multiple Myeloma
14
Lymphoma
14
Leukemia, Myeloid, Acute
14
Glioblastoma
14
Lymphoma, Non-Hodgkin
10
Neoplasms
9
Ovarian Neoplasms
8
Neoplasm Metastasis
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Colorectal Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Breast Neoplasms, Male
8
Myelodysplastic Syndromes
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Glioma
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Fallopian Tube Neoplasms
6
Osteosarcoma
5
Hodgkin Disease
5
Carcinoma, Renal Cell
5
Brain Neoplasms
5
Uveal Melanoma
4
Recurrence
4
Rectal Neoplasms
4
Medulloblastoma
4
Interventions
Temozolomide
74
Radiotherapy
34
Carboplatin
21
Bevacizumab
18
Magnetic Resonance Spectroscopy
17
Irinotecan
16
Carmustine
16
Vincristine
14
Surgical Procedures, Operative
13
Filgrastim
13
Procarbazine
10
Erlotinib Hydrochloride
8
Cyclophosphamide
8
Peripheral Blood Stem Cell Transplantation
7
O(6)-benzylguanine
7
Lomustine
7
Etoposide
7
sargramostim
6
Imatinib Mesylate
6
Flucytosine
6
Cisplatin
6
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
6
temsirolimus
5
Vorinostat
5
Thiotepa
5
Radiotherapy, Intensity-Modulated
5
Radiation
5
Immunohistochemistry
5
Biopsy
5
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Oligodendroglioma
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
Clear all
NCT06254326
2026-05-27
ADAGiO
University of Florida
Phase 1
Recruiting
12 enrolled